Dr. Rinfret is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 S Enota Dr NE
Gainesville, GA 30501Phone+1 770-599-2193
Summary
- Dr Stéphane Rinfret is an interventional cardiologist and world-renowned expert in CTO PCI. After a 20-year carreer in Canada, and 3 years at Emory from 2021-2023, he has now been appointed Director of Complex Coronary Intervention at the Georgia Heart Institute. He has published over 200 peer-reviewed articles and has been invited over 300 times to give lectures in the past 10 years. He is a high-volume coronary operator, with procedures performed predominantly in high-risk patients turned down for CABG or with complex post-CABG coronary anatomy. He is the founder and co-director of MLCTO, the largest CTO-dedicated course in Europe, and Editor of Percutaneous Coronary Intervention for Chronic Total Occlusion; the Hybrid Approach, 2nd Edition published by Springer Nature. Dr Rinfret serves as faculty in several cardiology meetings, and pursues very active clinical, research, proctoring and teaching career.
Education & Training
- University of Montreal Faculty of MedicineClass of 1992
Certifications & Licensure
- GA State Medical License 2021 - 2026
- FL State Medical License 2023 - 2025
Publications & Presentations
PubMed
- 97 citationsMeta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention.Dominique Joyal, Olivier F. Bertrand, Stéphane Rinfret, Avi Shimony, Mark J. Eisenberg
The American Journal of Cardiology. 2012-03-15 - 1858 citationsThe metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.Salvatore Mottillo, Kristian B. Filion, Jacques Genest, Lawrence Joseph, Louise Pilote
Journal of the American College of Cardiology. 2010-09-28 - 29 citationsCardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial.Olivier F. Bertrand, Paul Poirier, Josep Rodés-Cabau, Stéphane Rinfret, Lawrence M. Title
Atherosclerosis. 2010-08-01
Press Mentions
- Frequency and Outcomes of Ad Hoc Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the PROGRESS-CTO RegistryAugust 15th, 2023
Professional Memberships
- Fellow
- Society of Coronary Angiography and InterventionsFellow
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: